CBOE Legal and Regulatory Information
CBOE Corporate Documents and Rules
CBOE Corporate Documents and Rules
C2
C2 Legal & Regulatory
CBOE Rule Filings
CBOE Rule Filings
Circulars
Regulatory Circulars
Information Circulars
Compliance Highlights
Compliance Highlights
Exchange & Regulatory Bulletins
Exchange & Regulatory Bulletins
Regulatory Independence Policies
CBOE Holdings Regulatory Independence Policy for Non-Regulatory Group Personnel
CBOE Holdings Regulatory Independence Policy for Regulatory Group Personnel
Regulation SHO
Regulation SHO
National Market System Plans
View various NMS Plans
Disciplinary Information
Disciplinary Actions
Disciplinary Process Information for Customers
Disciplinary Process Information for Members
Arbitration
Click here for various types of arbitration documents such as guidelines for initiating an arbitration claim, claim forms, answer forms, uniform submission agreements, arbitration procedures and rules, lawyer referral services, and more.
Comment Letters
CBOE Comment Letters
Select SEC Letters to CBOE and SEC Releases
Departmental Overviews
Click here for an overview of the following Departments:
Designated Primary Market-Maker (DPM) Administration, Information Access and Development, Market Quality Assurance, Market Regulation, Member Firm Regulation, Membership, Regulated Entities, Regulatory Liaison, and Regulatory Planning and Strategy.
Comment/Complaint Forms
Click here to access CBOE's Member and/or Investor Comment/Complaint Forms.
If you need assistance, please e-mail the appropriate parties in the Contact CBOE form.
Options involve risk and are not suitable for all
investors. Prior to buying or selling an option, a person must receive a copy
of Characteristics and Risks of Standardized
Options (ODD). Copies of the ODD are available from your broker, by
calling 1-888-OPTIONS, or from The Options Clearing Corporation, One North
Wacker Drive, Suite 500, Chicago, Illinois 60606. The information on this
website is provided solely for general education and information purposes and
therefore should not be considered complete, precise, or current. Many of the
matters discussed are subject to detailed rules, regulations, and statutory
provisions which should be referred to for additional detail and are subject to
changes that may not be reflected in the website information. No statement
within the website should be construed as a recommendation to buy or sell a
security or to provide investment advice. The inclusion of non-CBOE
advertisements on the website should not be construed as an endorsement or an
indication of the value of any product, service, or website. The
Terms and Conditions govern use of this website and use of this website
will be deemed acceptance of those Terms and Conditions.
3rd party Adverstisement